IR News

by Category

Sustainability

Aug. 31, 2022 (PDF/477KB)Sustainability

Sumitomo Pharma Selected for Inclusion as a Constituent of Five GPIF-Adopted ESG Indexes that Cover Japanese Stocks
Apr. 08, 2022 (PDF/129KB)Sustainability

Switch to 100% Renewable Energy for Electric Power Purchased by Suzuka Plant
Mar. 22, 2022 (PDF/119KB)Sustainability

Sumitomo Dainippon Pharma Provides Material Assistance to Ukraine
Mar. 16, 2022 (PDF/121KB)Sustainability

Sumitomo Dainippon Pharma Enacts Basic Policy for Respecting Human Rights
Dec. 17, 2021Sustainability

Posted Video of ESG Meeting (Discussion with Investors) [Webcast]
Dec. 08, 2021 (PDF/2,718KB)Sustainability

ESG Meeting (Discussion with Investors)
Nov. 02, 2021 (PDF/223KB)Sustainability

Sumitomo Dainippon Pharma Announces Support for the Recommendations of the Task Force on Climate-related Financial Disclosures (TCFD)
Aug. 04, 2021 (PDF/115KB)Sustainability

Sumitomo Dainippon Pharma Listed Continuously in FTSE4Good Index Series and FTSE Blossom Japan Index of ESG Indices
May 12, 2021 (PDF/135KB)Sustainability

Sumitomo Dainippon Pharma Revises Its Basic Environmental Policies
Apr. 09, 2021 (PDF/113KB)Sustainability

Sumitomo Dainippon Pharma Receives the "Intellectual Property Achievement Awards" for the First Time
Mar. 04, 2021 (PDF/125KB)Sustainability

Sumitomo Dainippon Pharma Earns Recognition for the First Time in the Health & Productivity Management Stock Selection
Dec. 25, 2020Sustainability

Posted Video of ESG Meeting (Discussion with Investors) [Webcast]
Dec. 18, 2020 (PDF/2,408KB)Sustainability

ESG Meeting (Discussion with Investors)
Jul. 20, 2020 (PDF/139KB)Sustainability

Sumitomo Dainippon Pharma Listed in FTSE4Good Index Series of Socially Responsible Investment
Jul. 16, 2020 (PDF/83KB)Sustainability

Sumitomo Dainippon Pharma Contributes to the Relief Efforts for the Heavy Rain Event of July 2020 in Japan
Apr. 28, 2020 (PDF/253KB)Sustainability

Donation of Medical Protective Equipment (Face Shields, Masks and Gowns) to Support Measures against Coronavirus Disease 2019 (COVID-19)
Mar. 31, 2020 (PDF/85KB)Sustainability

Donations to the Kitasato Institute's Project for COVID-19 for Early Identification of Therapeutic Medicine for its Treatment
Jan. 29, 2020 (PDF/102KB)Sustainability

Donations for the Prevention of Pneumonia Caused by the New Coronavirus in China
Dec. 02, 2019Sustainability

Posted Video of ESG Meeting (Discussion with Investors) [Webcast]
Nov. 27, 2019 (PDF/2,758KB)Sustainability

ESG Meeting (Discussion with Investors)
Oct. 21, 2019 (PDF/141KB)Sustainability

Sumitomo Dainippon Pharma Contributes to the Typhoon Hagibis in October 2019 in Japan
Jul. 25, 2019 (PDF/151KB)Sustainability

Sumitomo Dainippon Pharma Listed in FTSE4Good Index Series of Socially Responsible Investment and FTSE Blossom Japan Index
Jul. 09, 2019 (PDF/340KB)Sustainability

Sumitomo Dainippon Pharma and National Center for Global Health and Medicine Initiate International Project on Measures against Antimicrobial Resistance (AMR) and Promote the Proper Use of Antibiotics in Vietnam
Nov. 27, 2018Sustainability

Posted Video of ESG Meeting (Discussion with Investors) [Webcast]
Nov. 20, 2018 (PDF/2,067KB)Sustainability

ESG Meeting (Discussion with Investors)
Sep. 19, 2018 (PDF/79KB)Sustainability

Sumitomo Dainippon Pharma Contributes to the 2018 Hokkaido Eastern Iburi Earthquake Relief Efforts in Japan
Jul. 23, 2018 (PDF/80KB)Sustainability

Sumitomo Dainippon Pharma Contributes to the Relief Efforts for the Heavy Rain Event of July 2018 in Japan
Jun. 28, 2018 (PDF/100KB)Sustainability

Sumitomo Dainippon Pharma Contributes to Northern Osaka Earthquake Relief Efforts in Japan
Sep. 21, 2017 (PDF/158KB)Sustainability

Sumitomo Dainippon Pharma Announces First-ever Inclusion in Dow Jones Sustainability Indices (DJSI)
Jun. 30, 2017 (PDF/95KB)Sustainability

Sumitomo Dainippon Pharma Listed in FTSE4Good Index Series of Socially Responsible Investment for the 15th Consecutive Year
Jun. 01, 2017 (PDF/62KB)Sustainability

Sumitomo Dainippon Pharma Contributes funding to the Global Health Innovative Technology Fund (GHIT Fund) for the Second Period
Jul. 25, 2016 (PDF/131KB)Sustainability

Sumitomo Dainippon Pharma Listed in FTSE4Good Index Series of Socially Responsible Investment for the 14th Consecutive Year